↓ Skip to main content

Dove Medical Press

Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate

Overview of attention for article published in Neuropsychiatric Disease and Treatment, December 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
2 X users
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
53 Mendeley
Title
Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
Published in
Neuropsychiatric Disease and Treatment, December 2013
DOI 10.2147/ndt.s47087
Pubmed ID
Authors

Richard H Weisler, Lenard A Adler, Scott H Kollins, David W Goodman, Mohamed Hamdani, Bryan Dirks, Ann C Childress

Abstract

Attention-deficit/hyperactivity disorder (ADHD) symptom presentation across age and sex has not been fully elucidated. The present post hoc analyses qualitatively explored the baseline levels of ADHD symptomatology across subgroups in two clinical trials of children and adults with ADHD to elucidate differences in participant presentation. The response to treatment was examined to determine patterns of response among items of the ADHD Rating Scale IV.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 52 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 17%
Student > Doctoral Student 8 15%
Student > Bachelor 8 15%
Researcher 7 13%
Other 4 8%
Other 6 11%
Unknown 11 21%
Readers by discipline Count As %
Medicine and Dentistry 16 30%
Psychology 11 21%
Nursing and Health Professions 4 8%
Neuroscience 3 6%
Agricultural and Biological Sciences 2 4%
Other 5 9%
Unknown 12 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2023.
All research outputs
#7,356,343
of 25,374,917 outputs
Outputs from Neuropsychiatric Disease and Treatment
#948
of 3,132 outputs
Outputs of similar age
#80,841
of 320,964 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#9
of 53 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,964 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.